Moreover blocking TIGIT interactions with recombinant TIGIT-Fc molecules reduces CLL cell viability and interferes with the secretion of anti-apoptotic cytokines by CD4+ T cells [55]. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.